You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA
SBC: THREE C INSTITUTE FOR SOCIAL DEVELOPMT Topic: N/ALocation 1903 N HARRISON AVE, STE 101 CARY, NC 27513 United States N44MH0664102C $365 147.00 2 005 ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA Department of Health and Human Services National Institutes of Health SBIR PHS2006-1 THREE C INSTIT ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Adipose Derived Adult Stem Cells in Hepatic Regeneration
SBC: VESTA THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Liver failure secondary to hepatitis, hepatotoxin exposure, and cirrhosis threatens the lives of thousands in the United States alone. Estimates of yearly direct healthcare costs for liver disease in the U.S. range from $60 billion to over $100 billion. Vesta Therapeutics has developed proprietary technologies for the isolation and preservation of primary hepat ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Advanced Technology for Administration of the Teen-ASI
SBC: Health Outcomes Inc Topic: N/ADESCRIPTION (provided by applicant): We propose to conduct a clinical trial using a suite of web-based software products as well as a web portal that will help with standardized assessment, treatment planning, referral, and outcomes tracking for adolescent substance abuse treatment. Products will include the automated Internet version of the Self- Report Teen-Addiction Severity Index (SR-T-ASI Net ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
All Stars Technology: Web-Based Program Enhancements
SBC: TANGLEWOOD RESEARCH INC Topic: N/ADESCRIPTION (provided by applicant): The success of research-based prevention programs depends on the degree to which they are implemented with fidelity. This Phase II project will enhance All Stars, a drug abuse prevention program, by integrating web-based and multimedia technologies. Enhancements will improve program fidelity by making the program easier to deliver. They will improve effectivene ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
A Multi-Parameter Inorganic Carbon Measurement System
SBC: SUNBURST SENSORS, LLC Topic: 822NOAA requests proposals to develop a system for the measurement of pCO2, dissolved inorganic carbon (DIC) and total alkalinity (AT) for shipboard use. In response, Sunburst Sensors proposed integration of a novel approach for analysis of AT developed at the University of Montana (UM) with existing DIC and pCO2 analyzers developed by Burke Hales (OSU) and pH and pCO2 sensors developed at UM. In P ...
SBIR Phase I 2006 Department of Commerce -
A Novel Protection Device for Shock Wave Lithotripter
SBC: Genognomon, LLC Topic: N/ADESCRIPTION (provided by applicant): The shock wave lithotripsy (SWL) was first introduced successfully in clinical treatment in the earlier 1980s by Dornier Medical System in Germany. Now it has become the modality for urolithiasis diseases. However, SWL also causes acute renal injury, such as hemorrhage, hematoma, edema and enlargement of kidney. Although most patients recover well following ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
A Novel Protection Device for Shock Wave Lithotripter
SBC: Genognomon, LLC Topic: N/ADESCRIPTION (provided by applicant): The shock wave lithotripsy (SWL) was first introduced successfully in clinical treatment in the earlier 1980s by Dornier Medical System in Germany. Now it has become the modality for urolithiasis diseases. However, SWL also causes acute renal injury, such as hemorrhage, hematoma, edema and enlargement of kidney. Although most patients recover well following ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
A Novel Treatment in a Bioterrorism Model of Pneumonic Plague Targets A1 ARs
SBC: ENDACEA, INC Topic: N/ADESCRIPTION (provided by applicant): Yersinia pestis (Y. pestis), the causative agent of plague, is a Gram-negative bacillus that is classified as a Category A pathogen by the Centers for Disease Control and a logical choice as a biological weapon. It has the potential to generate mass casualties and initiate a global epidemic of pneumonic plague. A major virulence factor for Y. pestis is endotoxi ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Antisense Treatment for Thalassemia. Preclinical study.
SBC: ERCOLE BIOTECH, INC. Topic: N/ADESCRIPTION (provided by applicant): The ultimate goal of this project is treatment of beta-thalassemia, a genetic blood disease, with antisense oligonucleotides. The project is based on the technology developed by the PI in which antisense oligonucleotides are used to restore correct functioning of a defective gene rather than, as commonly practiced, to inhibit the expression of an undesirable ge ...
STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Antisense Treatment for Thalassemia. Preclinical study.
SBC: ERCOLE BIOTECH, INC. Topic: N/ADESCRIPTION (provided by applicant): The ultimate goal of this project is treatment of beta-thalassemia, a genetic blood disease, with antisense oligonucleotides. The project is based on the technology developed by the PI in which antisense oligonucleotides are used to restore correct functioning of a defective gene rather than, as commonly practiced, to inhibit the expression of an undesirable ge ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health